Do age-related macular degeneration and cardiovascular disease share common antecedents?

References

• Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–43.
   Google Scholar
• Hyman LG. Epidemiology of AMD. In: Hampton GR, Nelson PT, editors. Age-Related Macular Degeneration: Principles and Practice. New York: Raven Press Ltd.; 1992. 1–35.
   Google Scholar
• Egan KM, Seddon JM. Age-related macular degeneration: Epidemiology. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia: WB Saunders Co.; 1994. 1266–74.
   Google Scholar
• Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995;39:367–74.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. J Am Med Assoc 1994;272:1413–20.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Willett WC, Speizer FE,Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. J Am Med Assoc 1996;276:1141–6.
   Google Scholar
• Seddon JM, Hennekens CH. Vitamins, minerals, and macular degeneration. Arch Ophthalmol 1994;112:176–9.
   PubMed Web of Science ®Google Scholar
• Maguire MG. More pieces for the age-related macular degeneration puzzle. Ophthalmology 1997;104:5–6.
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1982;100:912–8.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Annual summary of births, marriages, divorces, and deaths: United States, 1993. Hyattsville, MD: Public Health Service; 1994.
   Google Scholar
• Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, Buring JE, Hennekens CH. The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406–16.
   Google Scholar
• Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758–66.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Cerebrovascular disease mortality and Medicare hospitalization—United States, 1980-1990. MMWR 1992;41:477–80.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services. The health consequences of smoking: cardiovascular disease: a report of the Surgeon General. Washington, DC: Government Printing Office; 1983.
   Google Scholar
• U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress: a report of the Surgeon General. Washington, DC: Government Printing Office; 1989.
   Google Scholar
• Doll R, Peto R. Mortality in relation to smoking: 20 years' observation on male British doctors. Br Med J 1976;2:1525–36.
   PubMed Web of Science ®Google Scholar
• Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317:1303–9.
   Google Scholar
• Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 1994;154:169–75.
   PubMedGoogle Scholar
• Kannel WB. Risk factors in hypertension. J Cardiovasc Pharm 1989;13(Suppl. I):54-S IO.
   Google Scholar
• Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305–13.
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: National Institutes of Health; 1993.
   Google Scholar
• National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 1993.
   Google Scholar
• Stamler J, Stamler R, Brown V, et al. Serum cholesterol. Doing the right thing. Circulation 1993;88:1954-6o.
   Google Scholar
• La Rosa J, Hunninghake D, Bush D, Criqui MB, Getz GS, Grundy SM, Rakita L, Robertson RM, Weisfeldt ML. The cholesterol facts: a summary of the evidence relating fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation 1990;81:1721–33.
   Google Scholar
• Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. J Am Med Assoc 1986;256:2835–8.
   PubMed Web of Science ®Google Scholar
• Willett WC. Nutritional epidemiology. New York: Oxford University Press; 1990.
   Google Scholar
• Hu FB, Stampfer NJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491–9.
   PubMed Web of Science ®Google Scholar
• Manson JE, Spelsberg A. Risk modification in the diabetic patient. In: Manson J, Ridker P, Gaziano J, Hennekens C, editors. Prevention of Myocardial Infarction. New York: Oxford University Press; 1996. 241–73.
   Google Scholar
• Centers for Disease Control and Prevention. Public health focus: prevention of blindness associated with diabetic retinopathy. MMWR 1993;42:191–5.
   PubMedGoogle Scholar
• Kuczmarski RJ, Flegal KM, Campbell SM. Increasing prevalence of overweight among US adults. J Am Med Assoc 1994;272:205-II.
   Google Scholar
• Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity: a reassessment. J Am Med Assoc 1987;257:353–8.
   PubMed Web of Science ®Google Scholar
• Powell KE, Thompson PD, Casperson CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 1987;8:253–87.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Sex-, age-, and region-specific prevalence of sedentary lifestyle in selected states in 1985-the behavioral risk factor surveillance system. MMWR 1987;3:195–204.
   Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464–68.
   Google Scholar
• Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245–50.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–61.
   PubMed Web of Science ®Google Scholar
• Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129–35.
   Google Scholar
• Buring JE, Hennekens CH. Aspirin. In: Manson J, Ridker P, Gaziano J, Hennekens C, editors. Prevention of Myocardial Infarction. New York: Oxford University Press; 1996. 308–20.
   Google Scholar
• Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342: 1007-ii.
   Google Scholar
• Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Arch Intern Med 1995;155:241–6.
   PubMedGoogle Scholar
• Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Int Med 1995;123: 860–72.
   Google Scholar
• Buring JE, Hennekens CH. Antioxi-dant vitamins and cardiovascular disease. Nutr Rev 1997;55:553–560.
   Web of Science ®Google Scholar
• Price JF, Fowkes FGR. Antioxidant vitamins in the prevention of cardiovascular disease: The epidemiologic evidence. Eur Heart J 1997;18:719–27.
   PubMed Web of Science ®Google Scholar
• Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33–41.
   Google Scholar
• Hyman LG, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213–27.
   PubMed Web of Science ®Google Scholar
• Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age-related macular degeneration. Br J Ophthalmol 1998;82:996–1002.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Flowerdew G, Smith E, Brody JA, Tso M. Factors associated with age-related macular degeneration: an analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128:700–I0.
   Google Scholar
• Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 1979;11:1197–201.
   Google Scholar
• Delaney WV, Oates RP. Senile macular degeneration: a preliminary study. Ann Ophthalmol 1982;14:2 I–4.
   Google Scholar
• Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration: an epidemiological study of moo aged individuals. Acta Ophthalmol 1992;70:66–72.
   Web of Science ®Google Scholar
• The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–8.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. Ophthalmology 1993;I00:406–14.
   Google Scholar
• Vinding T. Age-related macular degeneration. An epidemiological study of moo elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand 1995; 2I7(Suppl):1–32.
   Google Scholar
• Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 1998;1 16:583–7.
   Google Scholar
• Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol 1997;124:677–82.
   PubMed Web of Science ®Google Scholar
• Grunwald J, Hariprasad S, Dupont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol 1998;116:150–4.
   PubMed Web of Science ®Google Scholar
• Grunwald J, Hariprasad S, DuPont J, Maguire M, Fine S, Brucker A, Maguire A, Ho A. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 1998;39:385–90.
   PubMed Web of Science ®Google Scholar
• Holz F, Wolfensberger T, Piguet B, Gross-Jendroska M, Wells J, Minassian D, Chisholm I, Bird A. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994;101:1522–8.
   Google Scholar
• Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol 1995;142:404–9.
   Google Scholar
• Verhoeff FH. Pathogenesis of disciform degeneration of the macula. Arch Ophthalmol 1937;18:561–85.
   Google Scholar
• Kornzweig AL. Changes in the choriocapillaris with senile macular degeneration. Ann Ophthalmol 1977;9:753–64.
   PubMedGoogle Scholar
• Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-relatedmacular degeneration. Ophthalmology 1989;96:104–8.
   PubMed Web of Science ®Google Scholar
• Friedman E, ICrupsky S, Lane AM, Oak SS, Egan K, Gragoudas ES. Ocular blood flow velocity in agerelated macular degeneration. Ophthalmology 1995;102:640–6.
   PubMed Web of Science ®Google Scholar
• Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996;103: 871–7.
   Google Scholar
• Kini MM, Leibowitz HM, Colton T. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham Eye Study. Am J Ophthalmol 1978;85:28–34.
   Google Scholar
• Dickinson AJ, Sparrow JM, Duke AM, Thompson JR, Gibson JM, Rosenthal AR. Prevalence of age-related maculopathy at two points in time in an elderly British population. Eye 1997;1E301–14.
   Google Scholar
• Klein R, Klein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104;7–21.
   PubMed Web of Science ®Google Scholar
• Sparrow JM, Dickinson AJ, Duke AM, Thompson JR, Gibson JM, Rosenthal AR. Seven year follow-up of age-related maculopathy in an elderly British population. Eye 1997;11:315–24.
   PubMed Web of Science ®Google Scholar
• Seddon J, Hankinson S, Speizer F, Willett W. A prospective study of smoking and age-related macular degeneration. Am J Epidemiol 1995;241:Abstract 136.
   Google Scholar
• Christen WG, Glynn RJ, Manson SE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. J Am Med Assoc 1996;276:1147–51.
   Google Scholar
• Paetkau ME, Boyd TAS, Grace M, Bach-Mills J, Winship B. Senile disciform macular degeneration and smoking. Can J Ophthalmol 1978;113:67–71.
   Google Scholar
• Klein R, Klein BEK, Linton KLP, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:19o–200.
   Google Scholar
• Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm TB, Bird AC. Bilateral macular drusen in age-related degeneration. Ophthalmology 1994;101:1522–8.
   Google Scholar
• Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1518–23.
   Google Scholar
• Vingerling JR, Hofman A, Grobbee DE, De Jong PTVM. Age-related macular degeneration and smoking: The Rotterdam Study. Arch Ophthalmol 1996;114:1193–6.
   Google Scholar
• Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552–8.
   Google Scholar
• Pauleikhoff D, Wormald RP, Wright L, Wessing A, Bird AC. Macular disease in an elderly population. Ger J Ophthalmol 1992;1 :12–5.
   PubMedGoogle Scholar
• Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997;151:741–7.
   Google Scholar
• West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875–9.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK. Smoke gets in your eyes too. J Am Med Assoc 1996;276:1178–9.
   PubMed Web of Science ®Google Scholar
• Sperduto RD, Hiller R. Systemic hypertension and age-related macular degeneration in the Framingham Eye Study. Arch Ophthalmol 1986;104:216–9.
   PubMedGoogle Scholar
• Vidaurri JS, Pe'er J, Halfon ST, Halperin G, Zauberman H. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica1984;188:243–7.
   Google Scholar
• Albrink MJ, Fasanella RM. Serum lipids in patients with senile macular degeneration. Am J Ophthalmol 1963;55:709–13.
   PubMed Web of Science ®Google Scholar
• Landolfo V, DeSimone S. Senile macular degeneration and alteration of the metabolism of the lipids. Ophthalmologica Basel 1978;177:248–53.
   PubMed Web of Science ®Google Scholar
• Tsang NC, Penfold PL, Snitch PJ, Billson F. Serum levels of antioxidants and age-related degeneration. Documenta Ophthalmologica 1992;81:387–400.
   PubMed Web of Science ®Google Scholar
• Sanders TAB, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 1993;57:428–33.
   Google Scholar
• Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104: 1804–12.
   Google Scholar
• Seddon J, Ajani U, Sperduto R, et al. Dietary fat intake and age-related macular degeneration. Invest Ophthalmol Vis Sci (Abstract) 1994; 35:2003.
   Web of Science ®Google Scholar
• Mares-Perlman JA, Brady WE, Klein R, Van den Langenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743–8.
   PubMed Web of Science ®Google Scholar
• Savion N, Belkin M. Increased HDL and ARMD. Ophthalmology 1994;101:417–8.
   PubMed Web of Science ®Google Scholar
• Friedman E. Dietary fat and age-related maculopathy. Arch Ophthalmol 1996;114:235–6.
   PubMedGoogle Scholar
• Klein R, Klein BEK, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:1527–34.
   Google Scholar
• Vingerling JR, Klaver CC, Hofman A, De Jong PT. Epidemiology of agerelated maculopathy. Epidemiol Rev 1995;17:347–60.
   PubMed Web of Science ®Google Scholar
• Ajani UA, Willett W, Miller D, Haller J, Yannuzzi L, Blair N, Burton T, Seddon J. Alcohol consumption and neovascular age-related macular degeneration. Abstract. Am J Epidemiol 1993;138:646.
   Web of Science ®Google Scholar
• Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M. Moderate wine consumption is associated with decreased odds of developing agerelated macular degeneration in NHANES-1. J Am Geriatr Soc 1998;46: 1–7.
   Google Scholar
• Ritter LL, Klein R, Klein BE, Mares-Perlman JA, Jensen SC. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 1995;120:19o–6.
   Google Scholar
• Moss S, Klein R, Klein BE, Mares-Perlman JA, Jensen SL. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 1995;120:190–6.
   Google Scholar
• Smith W, Mitchell P. Alcohol intake and age-related maculopathy. Am J Ophthalmol 1996;122:743–5.
   PubMed Web of Science ®Google Scholar
• Seddon J, Cho E, Stampfer M, Spiegelman D, Speizer F, Rimm E, Willett W, Hankinson S. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Invest Ophthal Vis Sci 1999;40:5568.
   Web of Science ®Google Scholar
• Klein BEK, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalm Soc 1994;92:289–95.
   PubMedGoogle Scholar
• Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, deJong PTVM. Macular degeneration and early menopause: a case-control study. Br Med J 1995;310:1570–t.
   Web of Science ®Google Scholar
• Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust NZ J Ophthalmol 1997;25 Suppl. 1:S13–5.
   Google Scholar
• Hung S, Seddon JM. The relationship between nutritional factors and age-related macular degeneration. In: Bendich A, Deckelbaum R, editors. Preventive Nutrition: The Comprehensive Guide for Health Professionals. Totowa, NJ: Humana Press Inc.; 1997. 245–65.
   Google Scholar
• Sperduto RD, Ferris FL, Kurinij N. Do we have a nutritional treatment for age-related cataract or macular degeneration? Arch Ophthalmol 1990;108:1403–5.
   Google Scholar
• Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223–7.
   Google Scholar
• Anderson RE, ICretzer FL, Rapp LM. Free radicals and ocular disease. Adv Exp Med Biol 1994;366:73–86.
   PubMedGoogle Scholar
• Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31:291–306.
   PubMed Web of Science ®Google Scholar
• The Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;m:104–9.
   Google Scholar
• Mares-Perlman JA, Klein R, Klein BE, Greger IL, Brady WE, Palta M, Ritter LL. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996;114:991–7.
   Google Scholar
• Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M, Palta M. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113:1518–23.
   Google Scholar
• Vanden Langenberg G, Mares-Perlman J, Klein R, Klein B, Brady W, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998;148:204–14.
   PubMed Web of Science ®Google Scholar
• West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994;112:222–7.
   PubMed Web of Science ®Google Scholar
• Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol 1988;106:192–8.
   PubMed Web of Science ®Google Scholar
• Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1225–35.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Group. Age-Related Eye Disease Study (AREDS) Phase II Manual of Operations. Potomac, MD: The EMMES Corporation; 1992.
   Google Scholar
• McCully KS. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am J Pathol 1969;56:m–28.
   Web of Science ®Google Scholar
• Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992;268:877–81.
   PubMed Web of Science ®Google Scholar
• Malinow MR. Frontiers in medicine: Homocyst(e)ine and arterial occlusive diseases. J Int Med 1994;236:603–17.
   PubMed Web of Science ®Google Scholar
• Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049–57.
   PubMed Web of Science ®Google Scholar
• Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary heart disease. N Engl J Med 1997;337:230–6.
   PubMed Web of Science ®Google Scholar
• McCully KS. Homocysteine, folate, vitamin B6, and cardiovascular disease. J Am Med Assoc 1998;279:392–3.
   Web of Science ®Google Scholar
• Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042–50.
   PubMed Web of Science ®Google Scholar
• Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25:1924–30.
   PubMed Web of Science ®Google Scholar
• Perry U, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395–8.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 1998;279:359–64.
   PubMed Web of Science ®Google Scholar
• Arnesen E, Refsun H, Bonaa ICH, Ueland PM, Forde OH, Nordrehaug JE. Serum total cholesterol and coronary heart disease. Int J. Epidemiol 1995;24:704–9.
   PubMed Web of Science ®Google Scholar
• Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg TB. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993;270:2693–8.
   Google Scholar
• Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. J Am Med Assoc 1995;274:1526–33.
   PubMed Web of Science ®Google Scholar
• Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatments of hyperhomocys-teinemia in humans. J Nutr 1994;124:1927–33.
   Google Scholar
• Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency: The importance of adequate vitamin intake. J Am Med Assoc 1993;270:2726–7.
   PubMed Web of Science ®Google Scholar
• Reinhart RA, Gani K, Arndt MR, Broste SK. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med 1990;150:1629–33.
   PubMedGoogle Scholar
• Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994;343:75–9.
   Google Scholar
• Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373–81.
   Google Scholar
• Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. J Am Med Assoc 1994;272:1666–71.
   PubMed Web of Science ®Google Scholar
• Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario K, Tsutsumi A, Nakamura Y, Igarashi M. Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. Am J Epidemiol 1995;141:815–21.
   Google Scholar
• Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. J Am Med Assoc 1993;270:2195–9.
   Google Scholar
• Barnathan ES. Has lipoprotein 'little' (a) shrunk? J Am Med Assoc 1993;270:2224–5.
   Web of Science ®Google Scholar
• Albert CM, Hennekens CH, ODonell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. Fish consumption and risk of sudden cardiac death. J Am Med Assoc 1998;279:23–8.
   PubMed Web of Science ®Google Scholar
• Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997;66\(Suppl. 4):1020S–31S.
   Google Scholar
• Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. In: Holman, editor. Progress in Lipid Research. London: Pergamon Press; 1983. 79–131.
   Google Scholar
• Gong J, Rosner B, Rees DG, Berson EL, Weigel-DiFranco CA, Schaefer EJ. Plasma docosahexanoic acid levels in various genetic forms of retinitis pigmentosa. Invest Ophthalmol Vis Sci 1992;33:2596–602.
   PubMed Web of Science ®Google Scholar
• Anderson RE, Maude MB, Lewis RA, Newsome DA, Fishman GA. Abnormal levels of polyunsaturated fatty acids in autosomal dominant retinitis pigmentosa. Exp Eye Res 1987;44:155–9.
   Google Scholar
• Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537–47.
   PubMed Web of Science ®Google Scholar
• Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronarysyndromes: a TIMI 11A Substudy. J Am Coll Cardiol 1998;31: 1460–5.
   Google Scholar
• Liuzzo G, Biasucci LM, Gallimore JR. Hemostatic factors and the risk pectoris. N Engl J Med 1994;331:417–24.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–9.
   Google Scholar
• Danesh J, Collins R, Appleby P, Peto leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998;279:1477–82.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Killinsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefe.s Arch Clin Exp Ophthalmol 1985;223:69–76.
   Google Scholar
• Katz IM. Indomethacin. Ophthalmology 1981;88:455–8.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Phase I Study of corticosteroid treatment of degeneration. Number 97-EI-0151. Web site: http://www.cc.nih.gov/cc/ bin/clinicalstudies/wais/bold.pl?/u/ pfreling/www/studies/detail/A_97-EI-o151.html; 1998.
   Google Scholar
• Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 1994;11:51–67.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123:199–206.
   Google Scholar
• Klaver CCW, Wolfs RCW, Assink JJM, et al. Genetic risk of age-related maculopathy. Population-based Familial Aggregation Study. Arch Ophthalmol 1998;116:1646–51.
   PubMed Web of Science ®Google Scholar
• Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805–7.
   PubMed Web of Science ®Google Scholar
• Klein M, Maudlin W, Stoumbos V. Heredity and age-related macular degeneration: observations in monozygotic twins. Arch Ophthalmol 1994;112:932–7.
   Google Scholar
• Meyers S, Green T, Gutman F. A twin study of age-related macular degeneration. Am J Ophthalmol 1995;120:757–66.
   Google Scholar
• Seddon J, Samelson I, Page W, Neale M. Twin study of macular degeneration: methodology and application to genetic epidemiology studies. Invest Ophthalmol Vis Sci 1997;38:5676.
   Web of Science ®Google Scholar
• Aiello L. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 1997;29:354–62.
   PubMed Web of Science ®Google Scholar